AEHR Makes Progress: Sales and Profits Increase Thanks to Innovative Testing Platform and Positive Analyst Revision

Forward-Looking Insights

Market experts anticipate that Aehr Test Systems will generate roughly $11.5 million in revenue for the third quarter of 2026, marking both a year-over-year rise and an improvement compared to the $9.88 million reported in the previous quarter. The consensus estimate for earnings per share is $0.02, representing a notable shift from the prior quarter’s loss of $0.11 per share. Net income is expected to remain positive at about $0.06 per share, further highlighting the company’s recovery. JMP Securities recently upgraded AEHR to a Market Outperform rating and set a price target of $35, citing robust order growth and enhanced visibility within the semiconductor testing sector.

No significant downgrades have been issued, although earnings projections are still influenced by short-term macroeconomic uncertainties.

AEHR Stock Trend Overview

• Ticker: AEHR
• Name: Aehr Test Systems
• Closing Price: $44.320
• Exchange: NASDAQ
• Status: Closed
• Change: +$4.720 (+11.92%)

Review of Past Performance

During the second quarter of 2026, Aehr Test Systems reported $9.88 million in revenue and a net loss totaling $3.23 million, or $0.11 per share. Gross profit reached $2.54 million for the period. These results reflect ongoing challenges with costs and underused production capacity, but sequential improvements in order volume hint at a possible turnaround.

Recent Developments

In March 2026, Aehr Test Systems unveiled a new wafer-level testing platform aimed at supporting advanced packaging and 3D integrated circuit technologies. The product is scheduled for release in the third quarter of 2026 and is expected to strengthen the company’s position in fast-growing segments of the semiconductor industry. The CEO also participated in a panel at SEMICON West 2026, expressing optimism about the long-term prospects for test equipment. There were no major mergers, acquisitions, or significant personnel changes reported during this period.

Strategic Summary and Outlook

Aehr Test Systems appears to be entering a phase of positive momentum, with revenue growth and product innovation driving improved results. The forecasted $11.5 million in revenue and $0.02 earnings per share for the third quarter of 2026 represent a substantial recovery from the previous quarter’s figures.

Backtest: Absolute Momentum Long-only Strategy

• Entry Criteria: Initiate a long position in AEHR when the 252-day rate of change is positive and the closing price is above the 200-day simple moving average.
• Exit Criteria: Close the position if the price falls below the 200-day SMA, after holding for 20 trading days, or upon reaching a take-profit of +8% or stop-loss of −4%.
• Backtest Period: April 5, 2024 to April 5, 2026
• Risk Controls: Take-profit at 8%, stop-loss at 4%, maximum holding period of 20 days.

Backtest Results

• Total Return: 44.53%
• Annualized Return: 35.62%
• Maximum Drawdown: 42.07%
• Profit-Loss Ratio: 1.66

Trade Metrics

• Total Trades: 48
• Winning Trades: 20
• Losing Trades: 28
• Win Rate: 41.67%
• Average Holding Days: 2.92
• Maximum Consecutive Losses: 7
• Profit-Loss Ratio: 1.66
• Average Win Return: 14.42%
• Average Loss Return: 7.79%
• Largest Single Gain: 41.48%
• Largest Single Loss: 15.32%

Conclusion

Gross profit has stabilized at $2.54 million. The introduction of a new testing system and improved analyst ratings point to a favorable outlook for Aehr Test Systems in the near term, although broader economic challenges may impact results. Overall, the company’s strategic focus on product development and increasing order momentum suggest a promising setup for the third quarter of 2026 and future periods.